Clinical Trials in Arizona

Showing 13941-13960 of 16,770 trials

Seprafilm in the Reduction of Incidence of Bowel Obstruction in General Surgery

NCT00130715

The purpose of the study is to evaluate the efficacy of Seprafilm in reducing the incidence of bowel obstruction and to evaluate the incidence of all serious adverse events (SAEs) associated with the use of Seprafilm occurring within 30 days postoperatively, and the incidence of abdominopelvic abscess within 6 months postoperatively.

Intestinal ObstructionDigestive System Surgical Procedures

Genzyme, a Sanofi CompanyStarted Jun 1998

Scottsdale, Arizona, United States • Los Angeles, California, United States • Los Angeles, California, United States +18 more locations

COMPLETEDPhase 331 miles

SWOG-9321 Melphalan, TBI, and Transplant vs Combo Chemo in Untreated Myeloma

NCT00002548

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage cancer cells. Combining chemotherapy and radiation therapy with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy and radiation therapy and kill more cancer cells. It is not yet known which treatment regimen is more effective for multiple myeloma. PURPOSE: Randomized phase III trial to compare the effectiveness of melphalan, total-body irradiation, and peripheral stem cell transplantation with that of combination chemotherapy in treating patients who have previously untreated multiple myeloma.

Multiple Myeloma

SWOG Cancer Research Network899 participantsStarted Jan 1994

Scottsdale, Arizona, United States • Denver, Colorado, United States • Tampa, Florida, United States +31 more locations

Seprafilm in the Reduction of Incidence of Bowel Obstruction in General Surgery

SWOG-9321 Melphalan, TBI, and Transplant vs Combo Chemo in Untreated Myeloma

Find Trials by Condition in Arizona

A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years

NVA237 BID Versus Placebo Twelve-week Efficacy Study

A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects

Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®

Dialysis Clinical Outcomes Revisited (DCOR) Trial

Clinical Investigation of Expanded Designs of a Multifocal IOL

Study of Meloxicam Capsules to Treat Osteoarthritis Pain

S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis

A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women

Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin

Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD

Dose Ranging and Dose Frequency of LIPO-102

Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients

Protocol of the Combination of Bortezomib and Tipifarnib for Relapsed or Refractory Multiple Myeloma

Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.

Cognitive Behavioral Treatments for Depression in Chronic Illness

TeleQuit Smoking Cessation Program

Patient-Reported Outcomes in Adults With Congenital Heart Disease